We equip customers with key advantages through nanolithography solutions
We equip customers with key advantages through nanolithography solutions
Explore Nanolithography
Sorrento Therapeutics highlights the Sofusa® Drug Delivery System in Covid-19 Vaccine Development program
The Sofusa® Drug Delivery System, for which Sorrento Therapeutics use Obducat’s NIL technology to fabricate the nanotopography draped microneedles, was highlighted in Sorrento Therapeutics proprietary mRNA vaccine development program for COVID-19.
Obducat customer Sorrento Therapeutics reports positive results
Sorrento Therapeutics, a biopharmaceutical company, reports positive initial result in dosing with the Sofusa® Lymphatic Drug Delivery Device. Sorrento Therapeutics use Obducat’s NIL technology to fabricate the nanotopography draped microneedles used in the Sofusa® Drug Delivery System.
Nanotechnology explained
Nanotechnology is about the ability to see and to control individual atoms and molecules. It is typically measured in nanometres and the technology can be applied across many fields such as chemistry, biology, physics, materials science and engineering.
Obducat is an innovative developer and world-leading supplier of micro-and nano lithography solutions. We supply the technology, products and processes used for advanced micro- and nanopatterning of surfaces.
Upcoming events
SPIE. Photonics West
January 25-27, 2022
San Francisco, USA
Visit us there!
http://www.spie.org
Press Release
Obducat receives order for an EITRE® 8 NIL-system from a customer in Asia
OBDUCAT AB (publ) subsidiary Obducat Technologies AB, a leading supplier of lithography solutions based on nanoimprint lithography (NIL), has received an order from a customer in Asia, for the supply of an EITRE 8 NIL-system. The order value amounts to approx. 3.4 million SEK. The EITRE 8 system will be installed in the cleanroom facilities…
Read more